On- and post-treatment symptom relief by repeated instillations of heparin and alkalized lidocaine in interstitial cystitis

International Journal of Urology

Volumn 20, Issue 11, 2013, Pages 1118-1122

  Nomiya, Akira ^a   Naruse, Takashi ^a   Niimi, Aya ^a   Nishimatsu, Hiroaki ^a   Kume, Haruki ^a   Igawa, Yasuhiko ^a   Homma, Yukio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Heparin; Interstitial cystitis; Intravesical instillation; Lidocaine

Indexed keywords

ALKALIZED LIDOCAINE; BICARBONATE; HEPARIN; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; SUPLATAST TOSYLATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; INTERSTITIAL CYSTITIS; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; O LEARY AND SANT SYMPTOM INDEX; PRIORITY JOURNAL; VISUAL ANALOG SCALE;

HEPARIN; INTERSTITIAL CYSTITIS; INTRAVESICAL INSTILLATION; LIDOCAINE;

ADMINISTRATION, INTRAVESICAL; ADULT; AGED; AGED, 80 AND OVER; ANESTHETICS, LOCAL; ANTICOAGULANTS; CYSTITIS, INTERSTITIAL; DRUG THERAPY, COMBINATION; FEMALE; HEPARIN; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84886792669     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/iju.12120     Document Type: Article

References (14)

1. Abrams P, Cardozo L, Griffiths D etal. The standardization of terminology of lower urinary tract function: report from the Standardization Sub-committee of the International Continence Society. Neurourol. Urodyn. 2002; 21: 167-178.
2. Homma Y, Ueda T, Tomoe H etal. Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome. Int. J. Urol. 2009; 16: 597-615.
3. Hill JR, Isom-Batz G, Panagopoulos G, Zakariasen K, Kavaler E. Patient perceived outcomes of treatments used for interstitial cystitis. Urology 2008; 71: 62-66.
4. Ito T, Ueda T, Homma Y, Takei M. Recent trends in patient characteristics and therapeutic choices for interstitial cystitis: analysis of 282 Japanese patients. Int. J. Urol. 2007; 14: 1068-1070.
5. Hanno PM, Wein AJ. Conservative therapy of interstitial cystitis. Semin. Urol. 1991; 9: 143-147.
6. Lilly JD, Parsons CL. Bladder surface glycosaminoglycans: a human epithelial permability barrier. Surg. Gynecol. Obset 1990; 171: 493-496.
7. Parsons CL, Housley T, Schmidt JD, Lebow D. Treatment of interstitial cystitis with intravesical heparin. Br. J. Urol. 1994; 73: 504-507.
8. Henry R, Patterson L, Avery N etal. Absorption of alkalized intravesical lidocaine in normal and inflamed bladders: a simple method for improving bladder anesthesia. J. Urol. 2001; 165: 1900-1903.
9. Parson CL. Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urol. 2005; 65: 45-48.
10. Propert KJ, Mayer R, Nickel JC etal. Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo. J. Urol. 2008; 179: 552-555.
11. Hanno PM, Landis JR, Matthews-Cook Y etal. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J. Urol. 1999; 161: 553-557.
12. Welk BK, Teichman JM. Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin. Urology 2008; 71: 67-70.
13. Baykal K, Senkul T, Sen B, Karademir K, Adayener C, Erden D. Intravesical heparin and peripheral neuromodulation on interstitial cystitis. Urol. Int. 2005; 74: 361-364.
14. Liu HT, Tyagi P, Chancellor MB, Kuo HC. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. BJU Int. 2009; 104: 1476-1481.